Intracranial Metastasis
Intracranial Metastasis - Related Videos
08:28
Experimental Metastasis Assay
0 Views •
Cited by 28 •
2010
This article describes the procedures of an experimental metastasis assay that is used to determine the metastatic potential of human cancer cell lines.
11:43
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
0 Views •
Cited by 6 •
2016
The ability of metastatic clones to colonize distant sites depends on their proliferation capacity and/or their ability to survive in the host microenvironment without significant proliferation. Here, we present an animal model that allows quantitative visualization of both types of liver colonization by metastatic clones.
08:49
Models of Bone Metastasis
0 Views •
Cited by 115 •
2012
Animal models are frequently utilized to study cancer metastasis to bone. In this protocol we will describe two common methods of tumor inoculation for bone metastasis studies and briefly describe some of the analyses utilized to monitor and quantify these models.
02:30
Metastasis
0 Views •
2021
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body. Epithelial-to-Mesenchymal Transition The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:55
Intracranial Injection of Gut-Derived Microbial Metabolites in a Mouse Model
0 Views •
2025
Source: Liou, C. et al. Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice. J. Vis. Exp. (2022).This video demonstrates the intracranial injection of short-chain fatty acids (SCFAs) in a freely moving mouse to study their effects on brain-mediated behavior. An injector cannula is inserted into a guide cannula implanted in the mouse brain. After recovery, the mouse acclimates in a novel cage. SCFAs are then administered, and locomotor behavior is recorded.
FAQs
The blood-brain barrier is a central interface in this process because disseminated tumor cells must cross it or alter its function before establishing lesions in the brain. Studying these interactions helps explain how tumor cells gain access to intracranial tissue and why the barrier is also an important consideration when developing approaches for drug delivery.
Metastatic lesions develop within a brain microenvironment shaped by vascular, immune, and glial interactions. These components create tumor-brain communication that can influence how lesions establish and grow. Neuroscience research examines these relationships to identify mechanisms that support lesion progression and to find ways of limiting tumor growth while protecting surrounding neural function.
Neurological risk rises when intracranial lesions disrupt normal neural function. The consequences depend on how tumor growth interacts with brain tissue and other intracranial environments, including the meninges. This makes preservation of cognition and broader neurological function an important goal when evaluating disease mechanisms and considering treatments aimed at controlling lesion growth.
Magnetic resonance imaging supports the diagnosis and investigation of intracranial metastasis by providing a way to examine lesions within intracranial tissues. In neuroscience, MRI-based study connects visible lesion patterns with questions about tumor-brain interactions and neurological effects. It therefore contributes both to identifying disease involvement and to evaluating research questions about lesion behavior.
Drug delivery is important because treatment must reach tumor sites within an intracranial environment shaped by the blood-brain barrier and tumor-associated changes. Research therefore examines how therapeutic access can be improved without overlooking neural protection. This work is relevant to designing strategies that target lesions while maintaining cognition and other neurological functions.
Research on intracranial metastasis addresses two linked outcomes: limiting lesion growth and preserving cognition and neurological function. Resistance to therapy complicates efforts to control disease, while treatment effects must be considered in the context of the brain. Studying tumor-brain communication, drug delivery, and resistance together can guide more effective and neurologically protective approaches.